Adaptation to ceramide involves AKT/FOXO regulated novel triglyceride lipases

对神经酰胺的适应涉及 AKT/FOXO 调节的新型甘油三酯脂肪酶

基本信息

  • 批准号:
    9257441
  • 负责人:
  • 金额:
    $ 33.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-01 至 2019-04-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Triacylglycerols are a source of fatty acyl CoA and serve as stores of energy in organisms. They are mobilized during conditions of stress and high-energy activity for efficient energy production. Defects in mobilizing triacylglycerol results in several human disorders such as obesity, metabolic syndrome and is a complication of diabetes and cardiovascular disorders. The sphingolipid ceramide affects cellular energy metabolism by interfering with mitochondrial function. In a Drosophila model that accumulates ceramide, we investigated how it adapts to compromised energy levels and discovered AKT/FOXO regulated novel lipases that mobilize and integrate the use of triglycerides for energy consuming processes. Impairment of the function of these lipases leads to elevated triglycerides, increased sensitivity to starvation and cardiac dysfunction. Our data indicate the existence of a lipolytic pathway functioning across different organs that includes the two novel lipases and is active under both physiological and stress conditions. The goal of this proposal is to elucidate the mechanisitic details involved in the complex functioning of these lipases in physiological as well as pathological states that are associated with hypertriglyceridemia. The specific aims of this project are (1). Gain insight into the non-autonomous mode of action of CG8093 and CG6277 lipases (2). Identify components and pathways involved in the regulation of triglycerides by CG8093 and CG6277 through a genetic approach (3). Evaluate the role of CG8093 and G6277 lipases in hypertriglyceridemia associated with obesity and diabetes using Drosophila and mouse models. Upon completion of these aims, we hope to gain considerable insight into the mechanism of action of these lipases and their contribution to energy metabolism in physiological and stress conditions and identify components and pathways involved in the functioning of these lipases.
 性状(由申请人提供):三酰甘油是脂肪酰辅酶A的来源,在生物体中作为能量储存。它们在压力和高能量活动条件下被动员起来,以实现高效的能源生产。动员三酰甘油的缺陷导致几种人类疾病,如肥胖症、代谢综合征,并且是糖尿病和心血管疾病的并发症。鞘脂神经酰胺通过干扰线粒体功能影响细胞能量代谢。在积累神经酰胺的果蝇模型中,我们研究了它如何适应受损的能量水平,并发现了AKT/FOXO调节的新型脂肪酶,这些脂肪酶可动员和整合甘油三酯用于能量消耗过程。这些脂肪酶的功能受损导致甘油三酯升高,对饥饿和心脏功能障碍的敏感性增加。我们的数据表明,存在一个脂肪分解途径,在不同的器官,其中包括两个新的脂肪酶,是积极的生理和压力条件下。该建议的目的是阐明这些脂肪酶在与高胆固醇血症相关的生理和病理状态中的复杂功能所涉及的机制细节。本项目的具体目标是(1)。深入了解CG 8093和CG 6277脂肪酶的非自主作用模式(2)。通过遗传方法确定CG 8093和CG 6277调节甘油三酯的组分和途径(3)。使用果蝇和小鼠模型评价CG 8093和G6277脂肪酶在与肥胖和糖尿病相关的高脂血症中的作用。在完成这些目标后,我们希望能够深入了解这些脂肪酶的作用机制及其在生理和应激条件下对能量代谢的贡献,并确定参与这些脂肪酶功能的组分和途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

USHA R ACHARYA其他文献

USHA R ACHARYA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('USHA R ACHARYA', 18)}}的其他基金

Adaptation to ceramide involves AKT/FOXO regulated novel triglyceride lipases
对神经酰胺的适应涉及 AKT/FOXO 调节的新型甘油三酯脂肪酶
  • 批准号:
    9118308
  • 财政年份:
    2015
  • 资助金额:
    $ 33.95万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    7045994
  • 财政年份:
    2005
  • 资助金额:
    $ 33.95万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    7599588
  • 财政年份:
    2005
  • 资助金额:
    $ 33.95万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    8107800
  • 财政年份:
    2005
  • 资助金额:
    $ 33.95万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    8446421
  • 财政年份:
    2005
  • 资助金额:
    $ 33.95万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    7386649
  • 财政年份:
    2005
  • 资助金额:
    $ 33.95万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    8245706
  • 财政年份:
    2005
  • 资助金额:
    $ 33.95万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    7210558
  • 财政年份:
    2005
  • 资助金额:
    $ 33.95万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    6907795
  • 财政年份:
    2005
  • 资助金额:
    $ 33.95万
  • 项目类别:
MOD OF SPHINGOLIPID BIOSYNTHETIC PATHWAY RESCUES: PHOTORECEPTOR DEGENERATION
鞘脂生物合成途径拯救的模式:光感受器变性
  • 批准号:
    6977005
  • 财政年份:
    2003
  • 资助金额:
    $ 33.95万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了